News

1 in 4 sexually active women has used injectable birth control, administered into the muscle by a clinician, but many may be unaware of its association with meningioma, the most common brain tumor in adults. In Europe and Canada, the drug is mandated to carry a warning — but not in the U.S. David

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to the liver. Despite progress in surgical therapies aimed at eradicating the cancer, many of these

Early trial results from one of the largest randomized trials for the treatment of localized prostate cancer and using machine learning to identify patients at high-risk for acute care events from radiation therapy, are among the topics UCSF researchers and clinicians will discuss at the American

"Tangled string is a nuisance when knitting, but did you know that tangled string can also cause cancer?” asked Atreya Dey, PhD, a postdoctoral scholar at UC San Francisco’s Postdoc Slam competition on Sept. 17. Speaking to a live and virtual audience of nearly 600 at UCSF’s Genentech Auditorium at

A study led by UC San Francisco and UC Davis has concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children. The researchers examined data from nearly 4 million children and estimated that 1 in 10 blood cancers — some 3,000 cancers in all — may be

Public concern continues to grow about the harmful effects of pesticides and other environmental pollutants, especially for children. Pesticides have previously been linked to a higher risk of developing childhood leukemia. Now a new study shows that children with leukemia who were exposed to

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC remains around 5% to 10%. The first FDA-approved antibody-drug conjugate therapy for metastatic UC (mUC)